Rhabdomyolysis associated with pentamidine isethionate therapy for American cutaneous leishmaniasis.
Delobel
Pierre
P
Pradinaud
Roger
R
D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003402:Creatine Kinase / Q000378:metabolism; D006801:Humans; D007273:Injections, Intramuscular; D016773:Leishmaniasis, Cutaneous / Q000150:complications* / Q000188:drug therapy; D010419:Pentamidine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012206:Rhabdomyolysis / Q000139:chemically induced*
D000981:Antiprotozoal Agents; D010419:Pentamidine; D003402:Creatine Kinase